BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Scheller EL, Hankenson KD, Reuben JS, Krebsbach PH. Zoledronic acid inhibits macrophage SOCS3 expression and enhances cytokine production. J Cell Biochem 2011;112:3364-72. [PMID: 21751240 DOI: 10.1002/jcb.23267] [Cited by in Crossref: 21] [Cited by in F6Publishing: 21] [Article Influence: 2.1] [Reference Citation Analysis]
Number Citing Articles
1 Escudero ND, Mandalunis PM. Influence of bisphosphonate treatment on medullary macrophages and osteoclasts: an experimental study. Bone Marrow Res 2012;2012:526236. [PMID: 23008775 DOI: 10.1155/2012/526236] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 0.7] [Reference Citation Analysis]
2 Staines Boone AT, Alcántara-Montiel JC, Sánchez-Sánchez LM, Arce-Cano M, García-Campos J, Lugo Reyes SO. Zoledronate as effective treatment for minimal trauma fractures in a child with STAT3 deficiency and osteonecrosis of the hip. Pediatr Blood Cancer 2016;63:2054-7. [PMID: 27416072 DOI: 10.1002/pbc.26119] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.7] [Reference Citation Analysis]
3 Sarhan D, D'Arcy P, Wennerberg E, Lidén M, Hu J, Winqvist O, Rolny C, Lundqvist A. Activated monocytes augment TRAIL-mediated cytotoxicity by human NK cells through release of IFN-γ. Eur J Immunol 2013;43:249-57. [PMID: 22996291 DOI: 10.1002/eji.201242735] [Cited by in Crossref: 17] [Cited by in F6Publishing: 18] [Article Influence: 1.7] [Reference Citation Analysis]
4 Wonganan O, He YJ, Shen XF, Wongkrajang K, Suksamrarn A, Zhang GL, Wang F. 6-Hydroxy-3-O-methyl-kaempferol 6-O-glucopyranoside potentiates the anti-proliferative effect of interferon α/β by promoting activation of the JAK/STAT signaling by inhibiting SOCS3 in hepatocellular carcinoma cells. Toxicol Appl Pharmacol 2017;336:31-9. [PMID: 29031523 DOI: 10.1016/j.taap.2017.10.004] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 2.2] [Reference Citation Analysis]
5 de Barros Silva PG, Ferreira Junior AEC, de Oliveira CC, Brizeno LAC, Wong DVT, Lima Júnior RCP, Sousa FB, Mota MRL, Alves APNN. Chronic treatment with zoledronic acid increases inflammatory markers in periodontium of rats. J Oral Pathol Med 2017;46:1046-53. [PMID: 28865081 DOI: 10.1111/jop.12640] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 0.2] [Reference Citation Analysis]
6 Grimm S, Mundethu A, Symmank J, Hennig C, Walter C, Reichardt E, Wehrbein H, Jacobs C. Compressive force strengthened the pro-inflammatory effect of zoledronic acid on il-1ß stimulated human periodontal fibroblasts. Clin Oral Investig 2021;25:3453-61. [PMID: 33169272 DOI: 10.1007/s00784-020-03667-w] [Reference Citation Analysis]
7 Yazici O, Aksoy S, Ucar O, Ozdemir N, Demir M, Sendur MA, Arik Z, Yaman S, Eren T, Uncu D, Zengin N. Arrhythmias during and after zoledronic acid infusion patients with bone metastasis. Med Oncol 2013;30:609. [PMID: 23690271 DOI: 10.1007/s12032-013-0609-5] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
8 Tada Y, Hiroshima K, Shimada H, Shingyoji M, Suzuki T, Umezawa H, Sekine I, Takiguchi Y, Tatsumi K, Tagawa M. An intrapleural administration of zoledronic acid for inoperable malignant mesothelioma patients: a phase I clinical study protocol. Springerplus 2016;5:195. [PMID: 27026891 DOI: 10.1186/s40064-016-1893-2] [Cited by in Crossref: 2] [Cited by in F6Publishing: 7] [Article Influence: 0.3] [Reference Citation Analysis]
9 Wilson HM. SOCS Proteins in Macrophage Polarization and Function. Front Immunol 2014;5:357. [PMID: 25120543 DOI: 10.3389/fimmu.2014.00357] [Cited by in Crossref: 75] [Cited by in F6Publishing: 72] [Article Influence: 9.4] [Reference Citation Analysis]
10 Wang X, Sun R, Hao X, Lian ZX, Wei H, Tian Z. IL-17 constrains natural killer cell activity by restraining IL-15-driven cell maturation via SOCS3. Proc Natl Acad Sci U S A 2019;116:17409-18. [PMID: 31405974 DOI: 10.1073/pnas.1904125116] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 3.3] [Reference Citation Analysis]
11 Zhang Q, Atsuta I, Liu S, Chen C, Shi S, Shi S, Le AD. IL-17-mediated M1/M2 macrophage alteration contributes to pathogenesis of bisphosphonate-related osteonecrosis of the jaws. Clin Cancer Res 2013;19:3176-88. [PMID: 23616636 DOI: 10.1158/1078-0432.CCR-13-0042] [Cited by in Crossref: 78] [Cited by in F6Publishing: 43] [Article Influence: 8.7] [Reference Citation Analysis]
12 Anastasilakis AD, Polyzos SA, Delaroudis S, Bisbinas I, Sakellariou GT, Gkiomisi A, Papadopoulou E, Gerou S, Makras P. The role of cytokines and adipocytokines in zoledronate-induced acute phase reaction in postmenopausal women with low bone mass. Clin Endocrinol (Oxf) 2012;77:816-22. [PMID: 22676573 DOI: 10.1111/j.1365-2265.2012.04459.x] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.4] [Reference Citation Analysis]
13 Yakass MB, Franco D, Quaye O. Suppressors of Cytokine Signaling and Protein Inhibitors of Activated Signal Transducer and Activator of Transcriptions As Therapeutic Targets in Flavivirus Infections. J Interferon Cytokine Res 2020;40:1-18. [PMID: 31436502 DOI: 10.1089/jir.2019.0097] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
14 Holtmann H, Lommen J, Kübler NR, Sproll C, Rana M, Karschuck P, Depprich R. Pathogenesis of medication-related osteonecrosis of the jaw: a comparative study of in vivo and in vitro trials. J Int Med Res 2018;46:4277-96. [PMID: 30091399 DOI: 10.1177/0300060518788987] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 2.5] [Reference Citation Analysis]
15 de Barros Silva PG, Verde MEQL, Brizeno LAC, Wong DVT, Lima Júnior RCP, Sousa FB, Mota MRL, Alves APNN. Immune cell profile of dental pulp tissue treated with zoledronic acid. Int Endod J 2017;50:1067-76. [PMID: 27977859 DOI: 10.1111/iej.12734] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 0.6] [Reference Citation Analysis]
16 George EL, Truesdell SL, Magyar AL, Saunders MM. The effects of mechanically loaded osteocytes and inflammation on bone remodeling in a bisphosphonate-induced environment. Bone 2019;127:460-73. [PMID: 31301402 DOI: 10.1016/j.bone.2019.07.008] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
17 Kaneko J, Okinaga T, Hikiji H, Ariyoshi W, Yoshiga D, Habu M, Tominaga K, Nishihara T. Zoledronic acid exacerbates inflammation through M1 macrophage polarization. Inflamm Regen 2018;38:16. [PMID: 29977413 DOI: 10.1186/s41232-018-0074-9] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 3.3] [Reference Citation Analysis]
18 Ding Y, Zeng JC, Yin F, Zhang CL, Zhang Y, Li SX, Liu X, Zhang C, Xue QY, Lin H, Pei FX. Multicenter Study on Observation of Acute-phase Responses After Infusion of Zoledronic Acid 5 mg in Chinese Women with Postmenopausal Osteoporosis. Orthop Surg 2017;9:284-9. [PMID: 28960821 DOI: 10.1111/os.12338] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 2.8] [Reference Citation Analysis]
19 Zhang Q, Yu W, Lee S, Xu Q, Naji A, Le AD. Bisphosphonate Induces Osteonecrosis of the Jaw in Diabetic Mice via NLRP3/Caspase-1-Dependent IL-1β Mechanism. J Bone Miner Res 2015;30:2300-12. [PMID: 26081624 DOI: 10.1002/jbmr.2577] [Cited by in Crossref: 34] [Cited by in F6Publishing: 31] [Article Influence: 4.9] [Reference Citation Analysis]
20 Low ZY, Wen Yip AJ, Chow VTK, Lal SK. The Suppressor of Cytokine Signalling family of proteins and their potential impact on COVID-19 disease progression. Rev Med Virol 2021;:e2300. [PMID: 34546610 DOI: 10.1002/rmv.2300] [Reference Citation Analysis]
21 Park SJ, Yu Y, Zides CG, Beyak MJ. Mechanisms of reduced leptin-mediated satiety signaling during obesity. Int J Obes (Lond) 2022. [PMID: 35241786 DOI: 10.1038/s41366-022-01079-2] [Reference Citation Analysis]
22 Pedroso JAB, Ramos-Lobo AM, Donato J. SOCS3 as a future target to treat metabolic disorders. Hormones (Athens). 2019;18:127-136. [PMID: 30414080 DOI: 10.1007/s42000-018-0078-5] [Cited by in Crossref: 22] [Cited by in F6Publishing: 19] [Article Influence: 5.5] [Reference Citation Analysis]